Search Login Register

Glucagon (Glukagon) Summary

Description: A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511)

Also Known As: Glukagon; Glucagon (1-29); HG-Factor; Hyperglycemic-Glycogenolytic Factor; Proglucagon (33-61) Show All >>

Networked: 5042 relevant articles (196 outcomes, 423 trials/studies) for this Drug

Key Diseases for which Glucagon is Relevant

  1. Hypoglycemia (Reactive Hypoglycemia) : 53 outcomes 78 studies in 896 results
  2. Hyperglycemia : 14 outcomes 34 studies in 538 results
  3. Insulin Resistance : 8 outcomes 12 studies in 182 results
  4. Neoplasms (Cancer) : 6 outcomes 35 studies in 406 results
  5. Type 1 Diabetes Mellitus (Autoimmune Diabetes) : 6 outcomes 14 studies in 136 results
Show All >>

Drugs Related to Glucagon

  1. Insulin (Novolin)
  2. Glucose (Dextrose)
  3. Epinephrine (Adrenaline)
  4. Hormones
  5. C-Peptide
  6. Blood Glucose (Blood Sugar)
  7. Glucagon-Like Peptide 1 (GLP 1)
  8. Incretins
  9. Calcium
  10. Growth Hormone (Somatotropin)
Show All >>

Therapies Related to Glucagon

  1. Injections
  2. Pancreas Transplantation
  3. Transplantation (Transplant Recipients)
  4. Denervation
  5. Premedication
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.